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INTRODUCTION 
ADAMTS5 cleaves the extracellular matrix (ECM) proteoglycans 
aggrecan and versican, which are major components of cartilage and 
soft-tissues respectively. 1·' The aggrecanase activity is believed to be 
essential in the destructive process of arthritis, since mice with a deletion 
ofthe catalytic domain of ADAMTS5 are resistant to both inflammatory 
and instability induced arthritis-'.4 Whether arthritis is due to 
overproduction of aggrecanase by the chondrocytes or other joint tissues 
or to post-translational activation of aggrecanase present in the cartilage 
matrix is currently unresolved.'·• Adamts5 mutant mice and 
combinatorial mutants of Adamts4 and Adamis5 are apparently normal 
and little is kllown about the normal function of ADAMTS5 expressed 
in the musculoskeletal system. 3'4 '7 The goal of these studies was to 
identifY sites at which Adamts5 may function, by defming its expression 
in the nonnal murine musculoskeletal system and in an ex-vivo model of 
joint inflammation. 
METHODS 
Trangenic mice: 
Adamts5"'v+ mice (Jackson Laboratories, Bar Harbor, ME) were 
outbred for over eight generations into the C57Bl/6 strain and used 
under an approved protocol. These mice contain an IRES-LacZ cassette 
inserted into exon 2 ofAdamts5 which generates a null allele.' Tissues 
were obtained post-mortem at one week, six weeks and eight months of 
age after euthanasia done as per recommendations of the American 
Veterinary Association Panel on Anesthesia. Adamts51" 2 f+ animals were 
sacrificed at 8 weeks of age for the ex-vivo joint inflammation model, 
similar to femoral head cultures previously described? Adamts5+!+ mice 
served as a negative control for this analysis. 
IJ-Galactosidase (IJ-Gal) Staining, Tartrate Resistant Acic 
Phosphatase (TRAP) Staining, Histology and 
Immunohistochemistl-y (IHC): 
For determination of 13-Gal staining in normal tissues, a previously 
published protocol was used.' Tissues treated with cytokines were 
stained at 37 °C for 2 hours. They were then decalcified in EDTA, and 
paraffin-embedded for sectioning and histology. 
Immunostaining was done using the aggrecanase neo-epitope 
antibody anti-NITEGE (JSCNIT Affinity Bioreagents, Golden, CO), 
anti-PACE4 (Sigma, Saint Louis, J\10) or anti-endomucin antibodies 
overnight at 4C .. TRAP staining was done using a leukocyte acid 
phosphatase kit (Sigma, Saint Louis, MO). 
Ex-vivo model of joint inflammation: 
Animals were euthanized, the knee joint was sectioned sagittally in 
the midline using a scalpel, washed three times, then incubated with 
DMEM containing 10% fetal bovine serum for 48 hours at 37C with 5% 
C02. After 48 hours the media were removed and the knees were 
incubated" with either serum free DMEM with 1% streptomycin and 
penicillin with or without lOnglml ofiL-1 a and20nglml ofTNF-a for 
16, 48 and 96 hours. Tissues were then fixed and j3-gal stained as 
described above. 
RESULTS 
Tissues from Adamts.J'~ mice showed no ~-gal staining under the 
conditions used. Therefore, ~-gal staining represents Adamts5 
expression sites. Adamts5 was highly expressed at specific sites in the 
murine muscul!)skeletal system (Fig. 1). There was expression in 
osteoblasts, ligament fibroblasts, tenocytes, tenosynovium, developing, 
but not mature skeletal muscle, synovial fibroblasts, endothelial cells of 
the blood vessels in bone, as well as in the endothelium of bone marrow 
sinusoids. Surprisingly, there was only sparse, sporadic expression in 
normal articular chondrocytes and there was no expression in growih 
plate chondrocytes.. Of the joint tissues, the synovial and tenosynovial 
fibroblasts showed the highest expression levels. Juvenile mice at one 
week of age showed stronger Adamts5 expression in periosteal 
osteoblasts, bone marrow endothelial cells, and skeletal muscle 
compared to their eight month old counterparts. TRAP staining and 
endomucin staining confirmed that Adamts5 was not expressed by 
osteoclasts, but by endothelial cells closely associated with these cells. 
When treated with inflammatory cytokines joint cartilage showed an 
increase in aggrecan breakdown as measured by anti-NITEGE 
immunoreactivity, but there was no corresponding increase in Adamts5 
f3-gal staining. However, increasedAdamts5 expression was seen in 
tenocytes in response to treatment with inflammatory cytokines. 
Figure 1: LacZ expression in the 
musculoskeletal system. A. One tibial cortical bone shows 
expression in the periosteal osteoblasts (lOX). B. Six week-old patellar 
cartilage shows no expression in chondrocytes (lOX). C. Eight month-
old knee joint shows high expression levels in synovial tissue (40X). D. 
Eight month-old knee joint shows expression in' fibroblasts of the 
posterior cruciate ligament and fibrochondrocytes of its insertion ( 40X). 
Sections were counterstained with eosin (red) 
DISCUSSION 
ADAMTS5 is commonly viewed as being highly relevant to 
cartilage and arthritis. However, we found only sparse expression in 
normal articular cartilage and no expression in growth plate cartilage. 
Instead, Adamts5 was highly expressed in synovial fibroblasts in all 
synovial joints stained, suggesting that the synovium may be more 
important in the degenerative process of arthritis than previously 
recognized. Also, when treated with int1ammatory cytokines, aggrecan 
breakdown was stimulated in articular cartilage but there was no 
coinciding increase in intensity of Adamts5 expression in chondrocytes. 
This supports a potential role for post-translational modification and 
activation of the protease in inflammatory disease as previously 
suggested! 
Adamts5 was highly expressed in tenosynovium and tenocytes and 
induced in tenocytes by the proinflarnmatory cytokines IL-l and TNF a.. 
This potentially implicates Adamts5 in ECM turnover in tendons in both 
physiologic and inflammatory conditions. Indeed, the ADAMTS5 
substrates, aggrecan, versican and matrilins are located in tendon matrix. 
Adamts5 expression in synovial and tenosynovial fibroblasts along with 
the pleural surfaces of the organ cavities and the pericardium suggests 
that ADAMTS5 may have a role in lubrication.' These fmdings suggest 
investigation of the role of ADAMTS5 in specific musculoskeletal 
tissues and in pathologies affecting them. 
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